Douris Nicholas, Stevanovic Darko M, Fisher Ffolliott M, Cisu Theodore I, Chee Melissa J, Nguyen Ngoc L, Zarebidaki Eleen, Adams Andrew C, Kharitonenkov Alexei, Flier Jeffrey S, Bartness Timothy J, Maratos-Flier Eleftheria
Division of Endocrinology (N.D., D.M.S., f.M.F., T.I.C., M.J.C., J.S.F., E.M.-F.), Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215-5491; Institute of Medical Physiology (D.M.S.), School of Medicine, University of Belgrade, 11000 Belgrade, Serbia; Department of Biology and Center for Obesity Reversal (N.L.N., E.Z., T.J.B.), Georgia State University, Atlanta, Georgia 30302-4010; and Diabetes Research (A.C.A., A.K.), Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285-0001.
Endocrinology. 2015 Jul;156(7):2470-81. doi: 10.1210/en.2014-2001. Epub 2015 Apr 29.
Fibroblast growth factor 21 (FGF21) has multiple metabolic actions, including the induction of browning in white adipose tissue. Although FGF21 stimulated browning results from a direct interaction between FGF21 and the adipocyte, browning is typically associated with activation of the sympathetic nervous system through cold exposure. We tested the hypothesis that FGF21 can act via the brain, to increase sympathetic activity and induce browning, independent of cell-autonomous actions. We administered FGF21 into the central nervous system via lateral ventricle infusion into male mice and found that the central treatment increased norepinephrine turnover in target tissues that include the inguinal white adipose tissue and brown adipose tissue. Central FGF21 stimulated browning as assessed by histology, expression of uncoupling protein 1, and the induction of gene expression associated with browning. These effects were markedly attenuated when mice were treated with a β-blocker. Additionally, neither centrally nor peripherally administered FGF21 initiated browning in mice lacking β-adrenoceptors, demonstrating that an intact adrenergic system is necessary for FGF21 action. These data indicate that FGF21 can signal in the brain to activate the sympathetic nervous system and induce adipose tissue thermogenesis.
成纤维细胞生长因子21(FGF21)具有多种代谢作用,包括诱导白色脂肪组织褐变。尽管FGF21刺激的褐变源于FGF21与脂肪细胞之间的直接相互作用,但褐变通常与通过冷暴露激活交感神经系统有关。我们检验了这样一个假设,即FGF21可以通过大脑发挥作用,增加交感神经活动并诱导褐变,而不依赖于细胞自主作用。我们通过侧脑室注射将FGF21注入雄性小鼠的中枢神经系统,发现中枢给药增加了包括腹股沟白色脂肪组织和棕色脂肪组织在内的靶组织中的去甲肾上腺素周转率。通过组织学、解偶联蛋白1的表达以及与褐变相关的基因表达的诱导来评估,中枢FGF21刺激了褐变。当用β受体阻滞剂处理小鼠时,这些作用明显减弱。此外,无论是中枢还是外周给予FGF21,在缺乏β肾上腺素能受体的小鼠中均未引发褐变,这表明完整的肾上腺素能系统对于FGF21的作用是必需的。这些数据表明,FGF21可以在大脑中发出信号,激活交感神经系统并诱导脂肪组织产热。